Watchlist Price Alert

ASLAN Pharmaceuticals Lim... (ASLN)

NASDAQ: ASLN · Real-Time Price · USD

0.60

-0.10 (-14.27%)

At close: Jul 18, 2024, 10:00 PM

ASLAN Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-44.22M	-51.28M	-31.59M	-16.97M	-46.66M	-42.17M	-40.71M	-9M
Depreciation & Amortization	348.5K	331.75K	282.22K	297.76K	445.35K	241.76K	214.3K	75.49K
Stock-Based Compensation	2.7M	1.98M	2.19M	345.84K	43.78K	1.29M	1.15M	1.41M
Other Working Capital	1.91M	-316.18K	-4.92M	-545.3K	-42.2K	-280.6K	245.4K	619.76K
Other Non-Cash Items	6.03M	1.22M	1.86M	1.25M	815.29K	223.57K	1.17M	496.99K
Deferred Income Tax	-8.27M	n/a	-2.62M	125.55K	23.04M	-190.27K	744.92K	-24.52K
Change in Working Capital	-2.95M	9.35M	-4.12M	-97.59K	-3.49M	1.14M	3.07M	1.45M
Operating Cash Flow	-46.36M	-38.41M	-34M	-15.05M	-25.8M	-39.47M	-35.11M	-5.57M
Capital Expenditures	-10.78K	-27.11K	-48.81K	-5.06K	-2.99K	-23.08M	-306.44K	-454.02K
Cash Acquisitions	148.00	1.17K	n/a	1.21K	2.48M	n/a	n/a	620.14
Purchase of Investments	n/a	-16.51M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	16.6M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	353.14K	20.65K	4.77K	-2.47M	-11.13K	-33.82K	-147.62K
Investing Cash Flow	-10.63K	414.7K	-28.16K	927.00	5.38K	-23.09M	-331.24K	-520.74K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	10.72M	4.72M	109.87M	7.17M	19.09M	40.9M	33.81M	31.41M
Financial Cash Flow	10.72M	4.72M	109.87M	7.17M	19.09M	40.9M	33.81M	31.41M
Net Cash Flow	-35.65M	-33.27M	75.84M	-7.88M	-6.71M	-21.66M	-5.87M	24.15M
Free Cash Flow	-46.37M	-38.43M	-34.04M	-15.06M	-25.81M	-62.55M	-35.41M	-6.02M